Prof Arnold G. Vulto speaks with ecancer at ESMO 2018 in Munich about the economic impact of biosimilars for health systems.
He highlights the education for clinicians around the topic as a hurdle to their adoption.
For more on biosimilars, see the ecancer educational module, available here.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.